Novel Mutation in Splicing Donor of Dystrophin Gene First Exon in a Patient With Dilated Cardiomyopathy but No Clinical Signs of Skeletal MyopathyDepartment of Child Development, Kumamoto University School of Medicine, kimusige{at}kaiju.medic.kumamoto-u.ac.jp
Department of Child Development, Kumamoto University School of Medicine
Department of Child Development, Kumamoto University School of Medicine
Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Sojo University
Department of Child Development, Kumamoto University School of Medicine
Department of Child Development, Kumamoto University School of Medicine
Department of Clinical Chemistry and Informatics, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
Department of Child Development, Kumamoto University School of Medicine
Department of Child Development, Kumamoto University School of Medicine
Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Sojo University
Department of Child Development, Kumamoto University School of Medicine One cause of X-linked dilated cardiomyopathies is mutation of the dystrophin gene. We report the case of a young boy who suffered from dilated cardiomyopathy caused only by dystrophin-deficient cardiac muscle, but who did not present with any clinical signs of skeletal myopathy. Sequence analysis of the patient's dystrophin gene revealed the presence of a novel single point mutation at the first exon—intron boundary, inactivating the 5' splice site consensus sequence of the first intron. The lack of muscle weakness observed clinically can be explained by expression of the brain and Purkinje dystrophin isoforms in skeletal muscle.
Key Words: dilated cardiomyopathy dystrophin gene novel mutation
Journal of Child Neurology, Vol. 22, No. 7,
901-906 (2007) |
|
|||

